It was withdrawn from many developed markets in the early 1980s (in 1982 in the United States), being made a Schedule I drug in the U.S. in 1984.
In the United States it was withdrawn in 1982 and made a Schedule I drug in 1984. It was withdrawn from many developed markets in the early 1980s.
It was withdrawn from many developed markets in the early 1980s. In the United States it was withdrawn in 1982 and made a Schedule I drug in 1984.
It was withdrawn from many developed markets in the early 1980s. In the United States it was withdrawn in 1982 and made a Schedule I drug in 1984.